MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/jev2.12134

Медицинская библиотека · Journal of extracellular vesicles · 2021

Preclinical efficacy and clinical safety of clinical-grade nebulized allogenic adipose mesenchymal stromal cells-derived extracellular vesicles.

Shi Meng-Meng, Yang Qing-Yuan, Monsel Antoine, Yan Jia-Yang, Dai Cheng-Xiang, Zhao Jing-Ya, Shi Guo-Chao, Zhou Min, Zhu Xue-Mei, Li Su-Ke, Li Ping, Wang Jing, Li Meng, Lei Ji-Gang, Xu Dong, Zhu Ying-Gang, Qu Jie-Ming

Клиническое исследование I фазыСтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Mesenchymal stromal cell-derived extracellular vesicles (MSC-EVs) turn out to be a promising source of cell-free therapy. Here, we investigated the biodistribution and effect of nebulized human adipose-derived MSC-EVs (haMSC-EVs) in the preclinical lung injury model and explored the safety of nebulized haMSC-EVs in healthy volunteers. DiR-labelled haMSC-EVs were used to explore the distribution of nebulized haMSC-EVs in the murine model. Pseudomonas aeruginosa-induced murine lung injury model was established, and survival rate, as well as WBC counts, histology, IL-6, TNF-α and IL-10 levels in bronchoalveolar lavage fluid (BALF) were measured to explore the optimal therapeutic dose of haMSC-EVs through the nebulized route. Twenty-four healthy volunteers were involved and received the haMSC-EVs once, ranging from 2 × 108 particles to 16 × 108 particles (MEXVT study, NCT04313647). Nebulizing haMSC-EVs improved survival rate to 80% at 96 h in P. aeruginosa-induced murine lung injury model by decreasing lung inflammation and histological severity. All volunteers tolerated the haMSC-EVs nebulization well, and no serious adverse events were observed from starting nebulization to the 7th day after nebulization. These findings suggest that nebulized haMSC-EVs could be a promising therapeutic strategy, offering preliminary evidence to promote the future clinical applications of nebulized haMSC-EVs in lung injury diseases.

Для цитирования: Shi Meng-Meng, Yang Qing-Yuan, Monsel Antoine, Yan Jia-Yang, Dai Cheng-Xiang, Zhao Jing-Ya, Shi Guo-Chao, Zhou Min, Zhu Xue-Mei, Li Su-Ke, Li Ping, Wang Jing, Li Meng, Lei Ji-Gang, Xu Dong, Zhu Ying-Gang, Qu Jie-Ming. Preclinical efficacy and clinical safety of clinical-grade nebulized allogenic adipose mesenchymal stromal cells-derived extracellular vesicles.. Journal of extracellular vesicles. 2021. DOI: 10.1002/jev2.12134.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.